Why FibroGen Fell by More Than 9% on Wednesday
What happened
The rising stock market had many winners on Wednesday, but alas for its shareholders FibroGen(NASDAQ:FGEN) wasn’t one of them. The biotech’s shares declined by over 9% following a downgrade from a famous investment bank.
So what
Goldman Sachs…
